Intellectual Professionals LLP (India) organized three-days(?) 9th 2021 World IP Forum which attracted many distinguished speakers from around the globe. Below are selected presentation taken from the referenced speaker list. Detailed program is restricted to those who sign up to a conference web-site.
Topics include patent search & AI; patent analytics & AI, FTO, patent opposition/IPR proceedings, pharmaceutical patents, inventive step/obviousness, IP law updates, etc.
Registration link. Fees: $120 (access to technical sessions, 8AM-1PM EST] or $220 (+access for recordings during 10 days).
Patent Search
Applying AI to IP Search, Trends and Use Cases, Susan A Hallen, IP Management Solutions Manager, IBM Corporation, USA
What happens when prior art search is fast, easy, and fun? Sam Davis , CEO & Founder and Matthew Luby, Head of Client Services, Amplified, Japan
AI and Machine Learning in Patent Search Systems: Friend or Foe? Brad Buehler, COO and Jonathan Skovholt, Head of Patent Search Operations, Ensemble IP LLC, USA (was on the program of 2020 PIUG conference)
INTERGATOR Smart Search: Re-thinking of Patent Searching using Machine Learning, Heiko Wongel, Founder, Wongel IP, Germany
Session: Patent Discovery: If willful blindness and AI had a child, would it be good, bad or ugly?
Susanne Hantos, Senior Patent Counsel, Davies Collison Cave, Australia
Bettina de Jong, Secretary General of the PDG & Chairperson ISBQPIP, Netherlands
Sandra Mau Vice President - Cloud Solutions, Clarivate, USA
Doris Spielthenner, Co-Founder and President, Ambercite Australia
Audrey Yap, President at LESI & Managing Partner, Yusarn Audrey, Singapore
Patent Analytics
The future of patent analytics, Anna Maria Villa, Patent Expert, IPI - Federal Institute of Intellectual Property, Switzerland
Session: Patent Analytics - Current and Future (with AI & ML)
Al Etheridge, Founder, Atlanta Patent Services (APS), USA
Steve Harris, CTO, Cipher, UK
Madhav Kulkarni, Global Intellectual Capital Manager, Dow, India
Prateek Mohunta, COO, Sagacious IP, India
Jitin Talwar, Founder, XLPAT - TT Consultants, India
---------------------
Session: Meet the editors of World Patent Information
Jane List, Founder at Extract Information & Editor in Chief World Patent Information, UK
Prof. Dr. Martin G. Moehrle, Director of the IPMI at University of Bremen & Associate Editor, World Patent Information, Germany
Prof. Amy J. C. Trappey, Distinguished Professor at National Tsing Hua University & Associate Editor World Patent Information, Taiwan
-------------
Introducing ML4Patents.com a comprehensive resource for learning about the use of machine learning methods for Intellectual Property, Anthony Trippe, Managing Director, Patinformatics, LLC (also on the program of 2021 PIUG conference)
The impact of AI on the IP ecosystem, George Koomullil , Founder and CEO , Relecura Inc., USA
----------
FTO
Disclosure-Dedication Doctrine: A primer on the potential pitfalls of this U.S. form of non-infringement. Jeffrey Alan Hovden, Robins Kaplan LLP, USA
(see also: Hovden, J.A., Langer, O., McElveen, K., Pinahs, Eagle Pharms. Inc. v. Slayback Pharma LLC. Legal Updates. Robins Kaplan LLP. May 08, 2020.)
Opposition/IPR proceedings
Current trends in U.S. Inter Parties review proceedings before the US Patent Office, Christopher Scharff, Shareholde, McAndrews, Held & Malloy, Ltd.,USA
Using EPO Opposition files in US disputes. Edward J. Kelly, Ropes & Gray LLP, USA
Oppositions at the EPO. Laura Fe, Murgitroyd, Germany
(See also: Preparing for Opposition: A guide to conducting effective Opposition and Appeal Proceedings at the European Patent Office. Murgitroyd & Company November 2020. Proprietor’s Guide. 5 p. & Opponent’s Guide. 5 p.)
Andean Oppositions and Cancellations, Maria Cecilia Romoleroux, CorralRosales, Ecuador
An Evaluation of the Indian Patent Invalidation Model: Lessons for the Other WTO Member States. Muhammad Zaheer Abbas, Queensland University of Technology, Australia
(See also Abbas, M.Z., Community-based patent opposition model in India: Access to medicines, right to health and sustainable development. Ph.D Thesis.Queensland University of Technology. April 2020, 371 p. https://eprints.qut.edu.au/180843/)
Session: Patent office invalidation options in Japan, Australia, Singapore, and New Zealand – How to weigh up the options?
Hiroyuki Hashimoto, Shiga International Patent Office, Japan
Tracey Hendy, FPA Patent Attorneys, Australia
Desmond Tan, FPA Patent Attorneys, Singapore
Pharmaceutical Patents
Protection of chemical/biotech inventions in Japan with a comparative view. Minoru Kato, Minoru Kato Patent Attorney Firm, Japan
Current Developments in Vaccine and Pharmaceutical Patents in the US and China. Thomas T. Moga, Dykema Gossett PLLC, USA
Certificates of Supplementary Protection in Canada, Charles Boulakia, Ridout & Maybee LLP, Canada
Practical experiences of dealing with the Singapore patent linkage system. James Kinnaird, Marks & Clerk Singapore LLP, Singapore
Patenting Antibodies in the United States. Lisa L. Mueller, Casimir Jones, S.C., USA
Session: COVID-19 Medical IP Landscape: Western medicine vs Traditional Chinese Therapy
Prof. I-Hsin Lin, Buddhist Tzu Chi Hospital,Taiwan
Prof. Yun Ken, National Taiwan University of Science and Technology, Taiwan
Topic: COVID-19 Medical IP Landscape: Western medicine vs Traditional Chinese Therapy
Prof. Dr. Mei-Hsin Wang, Fellow, Royal Society of Chemistry, UK, Taiwan
Yueh-Lung Yang,Chang Gung Memorial Hospital, Taiwan
Inventive Step/Obviousness
Inventive step assessment at the EPO: The “purpose” - and its surprising consequences, Sabrina Duschner, Liane Heinze, Gerold Schick, and Corinna Sundermann, Fresenius Kabi, Deutschland GmbH, Germany
Developments in Obviousness Law in the United States — inherency and the Role of Secondary Considerations/Objective Indicia, Joseph M. Reisman, Knobbe, Martens, Olson & Bear, LLP, USA
IP Law Updates
Session: Updates on European IP law and IP challenges in 2021.
Sedzimir Chmurzynski and Justyna Rechnio, Polpharma S.A.,Poland
Karin Pramberger, Polpharma Group, Switzerland
Maria Pique Rivero, Farmaprojects SAU, Spain
German Patent Legislation Developments.Prof. Dr. Heinz Goddar, Boehmert & Boehmert, Germany
Legislation Update on French IP Law. Olivier Nicolle, IP/ON Global Law Firm. France
Patent Subject Matter Eligibility in the United States. Robert L. Stoll, Faegre Drinker Biddle & Reath LLP, USA
Canada’s new guidelines on patentable subject matter. Elliott Simcoe, Smart & Biggar, Canada
Session: IP in Emerging Markets: News from Brazil, India, Pakistan, Russia, South Africa & UAE
Larisa Lysenko, Dennemeyer Group, Russia
Suchi Rai, Dennemeyer Group, India
Christophe Van Zyl, Dennemeyer Group, South Africa
Claudio Szabas, Dennemeyer Group, Brazil
Jan Wrede, Dennemeyer Group, UAE
Beyond the Bay of Bengal: IP Rights in ASEAN (Malaysia & Myanmar Focus) P. Kandiah, KASS International Sdn Bhd, Malaysia
Vietnam'S IP Landscape 2020: IP Law Changes under Newly-Signed FTAS. Yen Pham, Schmitt & Orlov, Vietnam
Search
Community
Job Board
